Hyperadrenergic POTS: When the Brain's Brakes Fail

Your heart is pounding. Blood pressure is spiking. You're sweating through your shirt just standing in the kitchen. The tremor in your hands won't stop. Your doctor checks your labs and says your norepinephrine is through the roof. Diagnosis: hyperadrenergic POTS.

The treatment plan: a beta blocker. It helps with the heart rate — and for many people, that's a real relief. But it doesn't touch the question underneath: why is the system cranking that hard in the first place?

Hyperadrenergic POTS — sometimes called hyperPOTS — is a subtype of POTS characterized by excessive sympathetic nervous system activation, typically defined by standing norepinephrine levels above 600 pg/mL, often with blood pressure elevation on standing rather than just tachycardia (Raj, Circulation, 2013). The standard framing is that the sympathetic system is "overactive." That's not wrong, exactly — but it's incomplete. It describes what's happening without asking the question that actually matters: why is it overactive?

How the Brain Controls Sympathetic Activation

The sympathetic nervous system isn't a single switch. It's a layered system with outputs controlled at every level of the neuraxis — from the cerebral cortex down through the hypothalamus, brainstem, and spinal cord to the peripheral nerves. And the way this system is normally organized is important:

The lower, more primitive structures are the gas. The higher structures are the brakes.

The brainstem — particularly the rostral ventrolateral medulla (RVLM) — is the primary sympathetic premotor center. It drives beat-to-beat blood pressure, heart rate, and vascular tone (Guyenet, Nature Reviews Neuroscience, 2006). Left to itself, it runs. What normally holds it in check is descending inhibition from higher brain centers: the frontal cortex, the cerebellum, the hypothalamic circuits that modulate arousal.

When you want to activate the sympathetic system, you don't push the gas harder. You let off the brakes a little. Release some of the inhibition. The lower circuits do the rest.

In hyperadrenergic POTS, those brakes are failing.

The sympathetic system isn't being over-driven. It's being under-inhibited. That's a completely different problem with completely different treatment implications.

Same symptom — tachycardia, sweating, tremor — three different causes

Where in the Brain Does Sympathetic Inhibition Break Down?

Here's what makes hyperPOTS so hard to treat with a one-size-fits-all approach: the loss of inhibition can happen at any level of the neuraxis, and each level produces a different clinical picture (Benarroch, Mayo Clinic Proceedings, 1993).

The same label — "hyperadrenergic POTS" — can come from a frontal lobe that isn't inhibiting the limbic system, a hypothalamus that's lost its cortical restraint, a brainstem with a broken baroreflex, a spinal cord that's been released from reticular inhibition, or a peripheral nerve that's not closing the feedback loop. Without knowing which level is affected, you're guessing at treatment.

What Norepinephrine Actually Tells You

Your tilt test comes back: norepinephrine at 900 or 1,200 pg/mL. The interpretation: "Your sympathetic system is overactive."

But norepinephrine is just a currency. It's a neurotransmitter that lets one sympathetic nerve talk to the next (Goldstein, Clinical Autonomic Research, 2010). High NE means the brain is driving the signal hard. The question is why.

And the answer isn't singular:

Interpretation A: the feedback loop is broken. The nerve fires, releases NE, but the next nerve in the chain can't transmit the signal — small fiber neuropathy, damage to the postganglionic neuron. So the brain keeps firing more. And more. The norepinephrine piles up because the system is screaming into a broken phone line.

Interpretation B: the inhibition is missing. The peripheral nerves are fine. The central drive is genuinely too high because the brakes from cortex, cerebellum, or hypothalamus aren't engaging. The NE is high because the system is unrestrained, not because it's compensating.

Same lab number. Different mechanism. Different treatment.

And at a certain level of overdrive, the norepinephrine starts bleeding into adjacent chains. You're sweating when nothing requires sweating. Heart rate spikes during a phone call. Pupils dilate. GI motility tanks. That spread of activation across multiple output chains — that's the hallmark of a system that's lost its specificity. Not one that's targeting the right organ too aggressively.

Why Beta Blockers Miss the Point

A beta blocker blocks the adrenergic receptor at the end organ — the heart, the blood vessels. Heart rate drops. Palpitations ease. The anxiousness can improve. That part feels like relief.

But here's the problem.

If the sympathetic system is cranking because the inhibition from higher brain centers is missing, blocking the end organ doesn't restore the inhibition. The central drive is still there. It just can't reach the heart anymore.

So it cranks harder.

This is something many hyperPOTS patients recognize: the heart rate improves on a beta blocker, but the rest doesn't follow. Sweating stays. Blood pressure instability stays. Brain fog sometimes gets worse — because if the tachycardia was compensating for reduced cerebral perfusion, lowering it removes the compensation the brain was depending on.

Raj and colleagues at Vanderbilt found exactly this pattern: low-dose propranolol (20mg) improved POTS symptoms, but higher doses made patients worse (Raj et al., Circulation, 2009). Less was more. The tachycardia isn't the disease — it's the system trying to work around whatever isn't being addressed yet.

Why Hyperadrenergic POTS Causes So Many Symptoms at Once

Hyperadrenergic POTS produces a recognizable cluster:

• Tachycardia with blood pressure elevation on standing (not just HR, BP goes up too)
• Adrenaline surges — sudden waves of fight-or-flight, often at rest or at night
• Excessive sweating in situations that don't require it
• Tremor, muscle tension, postural rigidity
• Pupil changes (mydriasis)
• Anxiety that doesn't respond to psychological treatment — because it isn't psychological
• Histamine/mast cell activation — flushing, hives, food reactions

Every single one of these maps to sympathetic output chains running without adequate inhibition. The RVLM doesn't just control heart rate — it activates sudomotor (sweating), vasomotor (vessel tone), pilomotor (goosebumps), and pupillomotor outputs. When those chains all fire at once because the brakes from above have failed, you don't get one symptom.

You get the whole cluster. At the same time. For no apparent reason.

The anxiety deserves its own conversation. When the frontal lobe can't adequately suppress the limbic system, the result looks identical to anxiety. Racing heart. Sense of dread. Hypervigilance. Can't turn it off.

But it isn't generated by fearful thoughts. It's generated by disinhibited limbic output that the cortex can't contain. Therapy can help with coping. SSRIs may take the edge off. But neither addresses the structural mechanism — a frontal brake that's too weak to hold the limbic system in check.

If you've done the work in therapy and the anxiety hasn't budged, that's not a failure on your part. It may mean the mechanism was never cognitive to begin with.

MCAS, Histamine, and Sympathetic-Immune Coupling

Many hyperPOTS patients carry a second diagnosis: MCAS. Mast cell activation syndrome. Flushing, GI distress, hives, food reactions. The symptom overlap is so heavy that it naturally leads to separate labels and separate treatment tracks — which can make it harder to see the shared mechanism underneath.

But immune control is a subset of autonomic control. The insular cortex and cingulate gyrus — where primary immune outputs originate — are autonomic areas. The histamine response and mast cell activation are functionally related to sympathetic outputs.

When descending inhibition is lost — especially at the hypothalamic level or higher — you don't just get cardiovascular hyperactivation. You get immune hyperactivation running on the same unchecked circuit.

That's the patient who's suddenly allergic to everything after a head injury or viral illness. The inhibition that held all of these systems in check is gone. The immune system is running alongside the cardiovascular system without a governor.

What the Diagnostic Workup Should Actually Find

If hyperPOTS is a problem of failed inhibition at specific levels of the neuraxis, the evaluation needs to figure out which level.

A norepinephrine level and a beta blocker prescription are a starting point — but they're not the whole picture. The workup should also answer:

• Is the baroreflex intact? Impaired baroreflex sensitivity means the RVLM isn't getting accurate feedback from the baroreceptors, and beat-to-beat blood pressure regulation breaks down.
• Is cerebral perfusion adequate? Hypoperfusion can drive sympathetic activation as a compensatory response. If the tachycardia and hypertension are trying to maintain brain blood flow, treating them as the problem makes things worse.
• Where is the cortical/cerebellar function? Frontal underactivation releases the limbic system. Cerebellar dysfunction impairs the ability to modulate brainstem output. These are testable.
• Is there autonomic neuropathy? Small fiber neuropathy can break the feedback loop peripherally, driving central NE levels up as the brain compensates for lost signal transmission.
• What level of the neuraxis is producing the pattern? Cortical vs hypothalamic vs brainstem vs spinal vs peripheral — the treatment for each is different.

Treatment targets the specific level that's failing:

• Impaired frontal inhibition? Repetitive frontal activation tasks that rebuild the inhibitory pathway to the limbic system.
• Broken baroreflex? Graded postural challenges that retrain the pressure-sensing reflex arc.
• Cerebellar modulation deficit? Vestibular and oculomotor rehabilitation to restore brainstem modulation.
• Peripheral feedback failure? Address sensory input quality so the brain can finally close the loop.

The exercises for a hypothalamic-level problem are different from a brainstem-level problem. Without knowing where the inhibition is failing, it's easy to cycle through approaches that weren't aimed at the right target. Some work, some don't — and the reason often comes down to whether the evaluation identified the level before the treatment began.

Dr. Keiser is a board-certified chiropractic neurologist (DC, DACNB, FABBIR), not a medical doctor (MD/DO). This content is for educational purposes and does not constitute medical advice. It is not a substitute for professional medical evaluation, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific situation. Medication decisions should be made with your prescribing physician.

← Back to Blog